Data Bridge Market Research analyses that the analgesics market was valued at USD 49.02 billion in 2021 and is expected to reach USD 70.73 billion by 2029, registering a CAGR of 4.69% during the forecast period of 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Patient Epidemiology Analysis

Analgesics market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Read Full Report: https://www.databridgemarketresearch.com/reports/global-analgesics-...

COVID-19 Impact on Analgesics Market

The global analgesics market was impacted by the COVID-19 outbreak. The pandemic had a favourable impact on the market, since increased focus on personal health encouraged purchases of these medications. The demand for over-the-counter cold and cough medicines was already high, and nutritional supplements were likely to expand at a faster rate due to COVID-19. Furthermore, the European Medicines Agency has advised using non-steroidal anti-inflammatories (NSAIDs) such as ibuprofen and paracetamol to treat moderate COVID-19 symptoms at the lowest dose possible. Additionally, because geriatric population are more vulnerable to infection due to weakening immune systems and the lack of a vaccine or therapy, the number of older persons infected with COVID-19 was considerable. Hence, all these factors increased the demand of analgesics market during the pandemic period.

Recent Acquisition

In July 2021, Heron Therapeutics Inc. had announced the launch of ZYNRELEF. It's an extended-release solution for soft tissue or periarticular installation in adults to provide postsurgical analgesia for up to 72 hours following a bunionectomy, open inguinal herniorrhaphy, or total knee arthroplasty.
Global Analgesics Market Scope
The analgesics market is segmented on the basis of pain type, drug class, type, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Pain Type

Acute
Chronic
Drug Class

Nonsteroidal Anti-inflammatory Drug (NSAIDs)
Opioids
Salicylates
Others
Type

Prescription drugs
Over-the-counter (OTC) drugs
Route of Administration

Oral
Parenteral
Others
End-Users

Hospitals
Specialty Clinics
Homecare
Others
Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
Analgesics Market Regional Analysis/Insights
The analgesics market is analysed and market size insights and trends are provided by country, pain type, drug class, type, route of administration, end-users and distribution channel as referenced above.

The countries covered in the analgesics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the analgesics market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the growing prevalence of chronic and acute pain and rising healthcare expenditure will further propel the market’s growth rate in this region. Additionally, growing presence of major key players and rise in adoption of newer technologies will further propel the market’s growth rate in this region.

Asia-Pacific is expected to be the fastest growing region during the forecast period of 2022-2029 due to surging level of disposable income in this region. Also, development of healthcare infrastructure and rising number of generic drug manufacturer will further propel the market’s growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Analgesics Market Share Analysis
The analgesics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to analgesics market.

Some of the major players operating in the analgesics market are:

F. Hoffmann-La Roche Ltd. (Switzerland)
Mylan N.V. (U.S.)
Teva Pharmaceutical Industries Ltd. (Ireland)
Sanofi (France)
Pfizer Inc. (U.S.)
GlaxoSmithKline plc (U.K.)
Novartis AG (Switzerland)
Merck & Co., Inc. (U.S.)
AstraZeneca (U.K.)
Johnson & Johnson Private Limited (U.S.)
Hikma Pharmaceuticals PLC (U.K.)
Dr. Reddy’s Laboratories Ltd. (India)
Fresenius Kabi AG (Germany)
Aurobindo Pharma (India)
Bausch Health Companies Inc. (Canada)
Amneal Pharmaceuticals LLC. (U.S.)
Apotex Inc. (Canada)
Eli Lilly and Company (U.S.)
Cipla Inc. (U.S.)
Lupin (India)

https://www.databridgemarketresearch.com/reports/global-keloid-trea...

https://www.databridgemarketresearch.com/reports/global-optic-nerve...

https://www.databridgemarketresearch.com/reports/global-gastroenter...

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475

Email:- [email protected]